Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families, J Med Genet, vol.36, pp.115-118, 1999. ,
Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test, Human Molecular Genetics, vol.8, issue.11, pp.2055-2062, 1999. ,
DOI : 10.1093/hmg/8.11.2055
Malignant hyperthermia: A statistical review, Canadian Anaesthetists??? Society Journal, vol.277, issue.4, pp.293-315, 1970. ,
DOI : 10.1007/BF03004694
A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree, Human Molecular Genetics, vol.9, issue.10, pp.1515-1524, 2000. ,
DOI : 10.1093/hmg/9.10.1515
Positioning of major tryptic fragments in the Ca 21 release channel (ryanodine receptor) resulting from partial digestion of rabbit skeletal muscle sarcoplasmic reticulum, J Biol Chem, vol.268, pp.22642-22649, 1993. ,
Single-channel properties of the recombinant skeletal muscle Ca 21 release channel (ryanodine receptor), 1997. ,
Faster sequential genetic linkage computations, Am J Hum Genet, vol.53, pp.252-263, 1993. ,
Anaesthetic deaths in a family, Lancet, vol.2, p.45, 1960. ,
Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1), Proceedings of the National Academy of Sciences, vol.99, issue.26, pp.16725-16730, 2002. ,
DOI : 10.1073/pnas.012688999
A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility, Br J Anaesth, vol.56, pp.1267-1269, 1984. ,
Mutations in the RYR1 gene in Italian patients at risk for Malignant Hyperthermia: evidence for a cluster of novel mutations in the C-terminal region, Cell Calcium, vol.32, issue.3, pp.143-151, 2002. ,
DOI : 10.1016/S0143-4160(02)00138-0
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia, Genomics, vol.11, issue.3, pp.751-755, 1991. ,
DOI : 10.1016/0888-7543(91)90084-R
Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia, Genomics, vol.13, issue.4, pp.1247-1254, 1992. ,
DOI : 10.1016/0888-7543(92)90042-Q
Genotype-phenotype comparison of the Swiss malignant hyperthermia population, Human Mutation, vol.18, issue.4, pp.357-358, 2001. ,
DOI : 10.1002/humu.1203
Molecular genetic testing to diagnose malignant hyperthermia susceptibility, Journal of Clinical Anesthesia, vol.20, issue.3, pp.1076-1080, 2004. ,
DOI : 10.1016/j.jclinane.2007.12.011
Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia, Archives of Neurology, vol.61, issue.1, pp.106-113, 2004. ,
DOI : 10.1001/archneur.61.1.106
Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores, Neurology, vol.59, issue.2, pp.284-287, 2002. ,
DOI : 10.1212/WNL.59.2.284
Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees, Human Molecular Genetics, vol.3, issue.10, pp.1855-1858, 1994. ,
DOI : 10.1093/hmg/3.10.1855
Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes., Journal of Medical Genetics, vol.34, issue.4, pp.291-296, 1997. ,
DOI : 10.1136/jmg.34.4.291
Protocol for the Sequence Analysis of Ryanodine Receptor Subtype 1 Gene Transcripts from Human Leukocytes, Anesthesiology, vol.99, issue.2, pp.289-296, 2003. ,
DOI : 10.1097/00000542-200308000-00010
Detection of a Novel Ryanodine Receptor Subtype 1 Mutation (R328W) in a Malignant Hyperthermia Family by Sequencing of a Leukocyte Transcript, Anesthesiology, vol.99, issue.2, pp.297-302, 2003. ,
DOI : 10.1097/00000542-200308000-00011
Identification of Heterozygous and Homozygous Individuals with the Novel RYR1 Mutation Cys35Arg in a Large Kindred, Anesthesiology, vol.86, issue.3, pp.620-626, 1997. ,
DOI : 10.1097/00000542-199703000-00014
A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease, Proceedings of the National Academy of Sciences, vol.96, issue.7, pp.4164-4169, 1999. ,
DOI : 10.1073/pnas.96.7.4164
Identification of Novel Mutations in the Ryanodine-Receptor Gene (RYR1) in Malignant Hyperthermia: Genotype-Phenotype Correlation, The American Journal of Human Genetics, vol.62, issue.3, pp.599-609, 1998. ,
DOI : 10.1086/301748
Ryanodine receptor mutations in malignant hyperthermia and central core disease, Human Mutation, vol.5, issue.5, pp.410-417, 2000. ,
DOI : 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D
Malignant-Hyperthermia Susceptibility Is Associated with a Mutation of the a1-Subunit of the Human Dihydropyridine-Sensitive L-Type Voltage-Dependent Calcium-Channel Receptor in Skeletal Muscle, The American Journal of Human Genetics, vol.60, issue.6, pp.1316-1325, 1997. ,
DOI : 10.1086/515454
An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.9, issue.18, pp.2599-2608, 2000. ,
DOI : 10.1093/hmg/9.18.2599
Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Human Molecular Genetics, vol.10, issue.22, pp.2581-2592, 2001. ,
DOI : 10.1093/hmg/10.22.2581
Presence of Two Different Genetic Traits in Malignant Hyperthermia Families, Anesthesiology, vol.97, issue.5, pp.1067-1074, 2002. ,
DOI : 10.1097/00000542-200211000-00007
A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with MmD congenital myopathy with ophthalmoplegia, Hum Mol Genet, vol.12, pp.1-8, 2003. ,
The Incidence of Malignant Hyperthermia in Denmark, Anesth Analg, vol.64, pp.700-704, 1985. ,
DOI : 10.1007/978-4-431-68346-9_2
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects, Acta Anaesthesiologica Scandinavica, vol.33, issue.8, pp.955-966, 1997. ,
DOI : 10.1111/j.1399-6576.1997.tb04820.x
Novel Mutations in C-terminal Channel Region of the Ryanodine Receptor in Malignant Hyperthermia Patients, The Japanese Journal of Pharmacology, vol.88, issue.2, pp.159-166, 2002. ,
DOI : 10.1254/jjp.88.159
RyR1/RyR3 Chimeras Reveal that Multiple Domains of RyR1 Are Involved in Skeletal-Type E-C Coupling, Biophysical Journal, vol.84, issue.4, pp.2655-2663, 2003. ,
DOI : 10.1016/S0006-3495(03)75071-1
Novel repeats in ryanodine and IP3 receptors and protein O-mannosyl-transferases, Trends Biochem Sci, vol.25, pp.48-50, 2000. ,
Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia, Nature Genetics, vol.19, issue.1, pp.51-55, 1993. ,
DOI : 10.1006/abio.1987.9999
Mutation Screening of the RYR1 Gene in Malignant Hyperthermia: Detection of a Novel Tyr to Ser Mutation in a Pedigree with Associated Central Cores, Genomics, vol.23, issue.1, pp.236-239, 1994. ,
DOI : 10.1006/geno.1994.1483
Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia, British Journal of Anaesthesia, vol.79, issue.3, pp.332-337, 1997. ,
DOI : 10.1093/bja/79.3.332
RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes, Human Mutation, vol.5, issue.2, pp.88-97, 2002. ,
DOI : 10.1002/humu.10098
Recent advances in the diagnosis of malignant hyperthermia susceptibility: How confident can we be of genetic testing?, European Journal of Human Genetics, vol.11, issue.4, pp.342-348, 2003. ,
DOI : 10.1038/sj.ejhg.5200964
Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia, Brain, vol.126, issue.11, pp.2341-2349, 2003. ,
DOI : 10.1093/brain/awg244
Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations, Acta Anaesthesiologica Scandinavica, vol.52, issue.4, pp.692-698, 2002. ,
DOI : 10.1097/00000542-199602000-00009
Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families, Neuromuscular Disorders, vol.11, issue.6-7, pp.530-537, 2001. ,
DOI : 10.1016/S0960-8966(01)00202-4
Screening of the Entire Ryanodine Receptor Type 1 Coding Region for Sequence Variants Associated with Malignant Hyperthermia Susceptibility in the North American Population, Anesthesiology, vol.102, issue.3, pp.515-521, 2005. ,
DOI : 10.1097/00000542-200503000-00007
RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene, Journal of Medical Genetics, vol.41, issue.3, p.33, 2004. ,
DOI : 10.1136/jmg.2003.014274
Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia, Clinical Genetics, vol.64, issue.Suppl. 1, pp.178-184, 2001. ,
DOI : 10.1034/j.1399-0004.2001.590306.x
Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease, Journal of Biological Chemistry, vol.272, issue.42, pp.26332-26339, 1997. ,
DOI : 10.1074/jbc.272.42.26332
Measurement of Resting Cytosolic Ca2+ Concentrations and Ca2+ Store Size in HEK-293 Cells Transfected with Malignant Hyperthermia or Central Core Disease Mutant Ca2+ Release Channels, Journal of Biological Chemistry, vol.274, issue.2, pp.693-702, 1999. ,
DOI : 10.1074/jbc.274.2.693
Guidelines for molecular genetic detection of susceptibility to malignant hyperthermiadagger, British Journal of Anaesthesia, vol.86, issue.2, pp.283-287, 2002. ,
DOI : 10.1093/bja/86.2.283
Malignant Hyperthermia Testing in Patients with Persistently Increased Serum Creatine Kinase Levels, Anesthesia & Analgesia, vol.84, issue.5, pp.1038-1041, 1997. ,
DOI : 10.1097/00000539-199705000-00016
Functional analysis of the R1086 H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling, 2004. ,
Skeletal Muscle Ryanodine Receptor Is a Redox Sensor with a Well Defined Redox Potential That Is Sensitive to Channel Modulators, Journal of Biological Chemistry, vol.275, issue.47, pp.36556-36561, 2001. ,
DOI : 10.1074/jbc.M007613200
Glutathione Modulates Ryanodine Receptor from Skeletal Muscle Sarcoplasmic Reticulum: EVIDENCE FOR REDOX REGULATION OF THE Ca2+ RELEASE MECHANISM, Journal of Biological Chemistry, vol.272, issue.11, pp.7069-7077, 1997. ,
DOI : 10.1074/jbc.272.11.7069
A mutation in the human ryanodine receptor gene associated with central core disease, Nature Genetics, vol.28, issue.1, pp.46-51, 1993. ,
DOI : 10.1006/abio.1987.9999
Molecular Identification of the Ryanodine Receptor Pore-forming Segment, Journal of Biological Chemistry, vol.274, issue.37, pp.25971-25974, 1999. ,
DOI : 10.1074/jbc.274.37.25971